Person

Back to overview Show all

Projects as responsible applicant

Responsible applicant Institution of higher education Start End date Funding scheme

Immunotherapy. Open label Phase I/II study (GMP)
Mölling Karin University of Zurich - ZH 01.01.2001 31.12.2001 NRP 37 Somatic Gene Therapy

Significance of a novel WD-propeller-FYVE protein for signalling
Mölling Karin University of Zurich - ZH 01.04.2007 31.12.2008 Project funding (Div. I-III)

Nucleic acid based intervention of HIV replication
Mölling Karin University of Zurich - ZH 01.04.1997 31.05.2000 Project funding (special)

The role of the Raf kinase in normal and tumor cells during development and tumor formation
Mölling Karin University of Zurich - ZH 01.04.1997 30.11.2000 Project funding (Div. I-III)

Characterization of the nucleocapsid NC-protein of HIV-1
Mölling Karin University of Zurich - ZH 01.06.1994 31.12.1996 Project funding (special)

Analyse der Mil/Raf-Proteinkinase im Signalweg der Zelle
Mölling Karin University of Zurich - ZH 01.04.1994 31.03.1997 Project funding (Div. I-III)

Signalling of the Raf-kinase in complex biological systems
Mölling Karin University of Zurich - ZH 01.12.2000 31.03.2004 Project funding (Div. I-III)

Characterization of the interaction between c-Raf-1 and 14-3-3.
Mölling Karin University of Zurich - ZH 01.07.1995 30.09.1996 International short research visits

Development of vectors for gene therapy
Mölling Karin University of Zurich - ZH 01.02.1997 30.09.2000 NRP 37 Somatic Gene Therapy

Non-proliferative signaling by negative regulation of the Raf kinase cascade
Mölling Karin University of Zurich - ZH 01.10.2004 30.09.2006 Project funding (Div. I-III)

Projects as co-applicant

Responsible applicant Institution of higher education Start End date Funding scheme

The multidomain protein CNK: a regulator of the Raf kinase pathway and integrator of signaling pathways
Radziwill Gerald University of Zurich - ZH 01.06.2004 31.05.2006 Project funding (Div. I-III)

Isolation of c-Myb interacting proteins
Hovens Christopher Martin University of Zurich - ZH 01.10.1995 30.09.1998 Project funding (Div. I-III)

Chemoprotection of hematopoietic cells via topoisomerase IIa
Stahel Rolf University of Zurich - ZH 01.04.1996 31.05.1998 NRP 37 Somatic Gene Therapy

Targeting of dendritic cells for DNA vaccination
Walter Elke ETH Zurich - ETHZ 01.07.1999 31.12.2001 NRP 37 Somatic Gene Therapy

-